A family planning clinic is evaluating multiple patients who are seeking reliable, reversible contraception. Each patient has distinct medical comorbidities that impact the safety of various contraceptive methods according to the World Health Organization Medical Eligibility Criteria (WHO MEC). Match each patient's clinical presentation with the single most appropriate contraceptive method.
- A 34-year-old woman with poorly controlled hypertension (162/104 mmHg) and severe dysmenorrhea.Levonorgestrel-releasing intrauterine device
- A 28-year-old woman with systemic lupus erythematosus and positive antiphospholipid antibodies.Copper intrauterine device
- A 22-year-old woman with active Chlamydia trachomatis cervicitis who requests a long-acting contraceptive today.Subdermal etonogestrel implant
- A 38-year-old woman who smokes a pack of cigarettes daily and specifically requests a daily, orally administered contraceptive.Progestin-only pill (Norethindrone)
Answer
The hypertensive patient with dysmenorrhea should receive the Levonorgestrel-releasing intrauterine device. The patient with SLE and antiphospholipid antibodies should receive the Copper intrauterine device. The patient with active cervicitis should receive the Subdermal etonogestrel implant. The 38-year-old smoker desiring an oral method should receive the Progestin-only pill.
Each patient presentation highlights a specific WHO MEC Category 4 (absolute) or Category 3 (relative) contraindication. Estrogen is contraindicated in severe hypertension and in smokers over age 35. All hormones are contraindicated in patients with positive antiphospholipid antibodies. IUD placement is contraindicated during active cervical infections.
Step-by-Step Solution
Key Concept
World Health Organization Medical Eligibility Criteria (WHO MEC) for Contraceptive Use